Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001640334-24-001844
Filing Date
2024-12-05
Accepted
2024-12-05 16:56:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 lxrp_424b3.htm 424B3 105637
2 lxrp_424b3img3.jpg GRAPHIC 4983
3 lxrp_424b3img4.jpg GRAPHIC 4983
  Complete submission text file 0001640334-24-001844.txt   120792
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B3 | Act: 33 | File No.: 333-283484 | Film No.: 241529758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)